Richmond Hill, Canada

Gary Kc Tin

This inventor holds 1 USPTO granted patent. Top assignees: 2692372 Ontario, Inc., Dunad Therapeutics Ltd.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gary Kc Tin: Innovator in Pharmaceutical Chemistry

Introduction

Gary Kc Tin is a notable inventor based in Richmond Hill, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzenesulfonamide derivatives. His research focuses on the development of compounds that can disrupt proteins and polypeptides, which are crucial in the treatment of various diseases.

Latest Patents

Gary Kc Tin holds a patent for "Benzenesulfonamide derivatives and uses thereof." This patent includes benzenesulfonamide derivatives characterized by a specific formula, along with pharmaceutical compositions that incorporate these compounds. The methods described in the patent aim to utilize these compounds for disrupting protein and polypeptide functions, thereby providing potential treatments for diseases linked to these biological molecules. The compounds feature fluorinated benzene sulfonamide structures, which enhance their efficacy.

Career Highlights

Throughout his career, Gary has worked with several companies, including Dunad Therapeutics Ltd. and 2692372 Ontario, Inc. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in drug development and therapeutic solutions.

Collaborations

Gary has collaborated with notable professionals in his field, including Graham Simpson and Patrick T Gunning. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Gary Kc Tin is a distinguished inventor whose work in pharmaceutical chemistry has the potential to revolutionize treatment options for various diseases. His innovative approach to developing benzenesulfonamide derivatives showcases his commitment to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…